Target Name: ZNF318
NCBI ID: G24149
Review Report on ZNF318 Target / Biomarker Content of Review Report on ZNF318 Target / Biomarker
ZNF318
Other Name(s): Endocrine regulator | ZN318_HUMAN | TZF | zinc finger protein 318 | testicular zinc finger | HRIHFB2436 | endocrine regulator | Zinc finger protein 318 | Endocrine regulatory protein | endocrine regulatory protein | ZFP318 | Testicular zinc finger

ZNF318: A Non-Coding RNA Molecule with Potential as A Drug Target

ZNF318 (Zinc Finger Nucleotide-conjugated RNA-protein hybrid), also known as endocrine regulator, is a non-coding RNA molecule that plays a crucial role in regulating various physiological processes in the body. It is a key regulator of gene expression and has has been implicated in various diseases, including cancer, obesity, and neurodegenerative disorders. ZNF318 is a strong candidate drug target and has the potential to treat a range of diseases.

Structure and Function

ZNF318 is a small non-coding RNA molecule that consists of a core ZNF318 protein and a 22-nt non-coding RNA tail. The ZNF318 protein is a key regulator of gene expression and has been involved in the regulation of various cellular processes, including cell growth, differentiation, and inflammation. ZNF318 is expressed in various tissues and cells and has been shown to play a role in the regulation of stem cell proliferation and self-renewal.

The ZNF318 RNA molecule has been shown to have a variety of functions. It is a negative regulator of gene expression, which means that it can prevent the translation of mRNAs that are not targeted for translation. ZNF318 has been shown to interact with various protein partners , including transcription factors, to regulate their activity and prevent them from activating target genes. ZNF318 has also been shown to play a role in the regulation of DNA replication and cell cycle progression.

Disease association

ZNF318 is involved in the regulation of various diseases and conditions, including cancer, obesity, and neurodegenerative disorders. ZNF318 has been implicated in the development and progression of various cancers, including breast cancer, lung cancer, and colon cancer. has also been shown to be involved in the regulation of obesity, with studies showing that it can increase the expression of genes involved in lipid metabolism and reduce the expression of genes involved in energy expenditure.

In addition to its role in cancer and obesity, ZNF318 has also been implicated in the regulation of neurodegenerative disorders. ZNF318 has been shown to play a role in the regulation of neurogenesis, with studies showing that it can promote the proliferation and differentiation of neural stem cells. ZNF318 has also been shown to play a role in the regulation of synaptic plasticity, with studies showing that it can alter the expression of genes involved in synaptic development and function.

Candidate drug targets

ZNF318 has the potential to be a drug target for a range of diseases due to its involvement in various cellular processes. ZNF318 has been shown to play a role in the regulation of cell growth, differentiation, and inflammation, making it a potential target for anti- -cancer agents. ZNF318 has also been shown to play a role in the regulation of stem cell proliferation and self-renewal, making it a potential target for stem cell therapies. In addition, ZNF318 has been shown to play a role in the regulation of DNA replication and cell cycle progression, making it a potential target for anti-mitotic agents.

Conclusion

ZNF318 is a non-coding RNA molecule that has been shown to play a crucial role in regulating various physiological processes in the body. Its functions as a negative regulator of gene expression and its involvement in the regulation of various diseases make it a promising drug candidate target. Further research is needed to fully understand the role of ZNF318 in cellular processes and its potential as a drug target.

Protein Name: Zinc Finger Protein 318

Functions: Acts as a transcriptional corepressor for AR-mediated transactivation function. May act as a transcriptional regulator during spermatogenesis and, in particular, during meiotic division

The "ZNF318 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF318 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF319 | ZNF32 | ZNF32-AS1 | ZNF32-AS2 | ZNF32-AS3 | ZNF320 | ZNF321P | ZNF322 | ZNF322P1 | ZNF324 | ZNF324B | ZNF326 | ZNF329 | ZNF330 | ZNF331 | ZNF333 | ZNF334 | ZNF335 | ZNF337 | ZNF33A | ZNF33B | ZNF33BP1 | ZNF34 | ZNF341 | ZNF341-AS1 | ZNF343 | ZNF345 | ZNF346 | ZNF347 | ZNF35 | ZNF350 | ZNF350-AS1 | ZNF354A | ZNF354B | ZNF354C | ZNF355P | ZNF358 | ZNF362 | ZNF365 | ZNF366 | ZNF367 | ZNF37A | ZNF37BP | ZNF382 | ZNF383 | ZNF384 | ZNF385A | ZNF385B | ZNF385C | ZNF385D | ZNF385D-AS1 | ZNF385D-AS2 | ZNF391 | ZNF394 | ZNF395 | ZNF396 | ZNF397 | ZNF398 | ZNF402P | ZNF404 | ZNF407 | ZNF407-AS1 | ZNF408 | ZNF41 | ZNF410 | ZNF414 | ZNF415 | ZNF416 | ZNF417 | ZNF418 | ZNF419 | ZNF420 | ZNF423 | ZNF425 | ZNF426 | ZNF428 | ZNF429 | ZNF43 | ZNF430 | ZNF431 | ZNF432 | ZNF433 | ZNF433-AS1 | ZNF436 | ZNF436-AS1 | ZNF438 | ZNF439 | ZNF44 | ZNF440 | ZNF441 | ZNF442 | ZNF443 | ZNF444 | ZNF445 | ZNF446 | ZNF449 | ZNF45 | ZNF451 | ZNF454 | ZNF460